Extracellular Matrix Regulation of Fibroblast Viability
Extracellular Matrix Regulation of Fibroblast Viability
批准号:
7426960
负责人:
CRAIG A HENKE
金额:
$32.39万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-07-04 至 2009-05-31
关键词:
1-Phosphatidylinositol 3-Kinase3-DimensionalAddressAdhesionsAlveolar wallAlveolusAnatomyAntibodiesApoptosisArchitectureBiological ProcessCell physiologyCellsCicatrixCollagenCollagen Type ICytochalasin DCytoskeletonDataDepositionDiseaseDisease regressionEctopic ExpressionEnvironmentEquilibriumExtracellular MatrixFibroblastsFibronectinsFunctional disorderGasesGelHamman-Rich syndromeILK geneIn VitroInduction of ApoptosisInjuryIntegrinsInvestigationLeadLigationLungMediatingModelingMolecularMyofibroblastNR0B2 geneNocodazoleNormal tissue morphologyOrganPTEN genePTK2 genePathway interactionsPatientsPatternPhenotypePhosphoric Monoester HydrolasesPhosphorylationPhosphotransferasesPhysiologicalProcessProtein DephosphorylationRegulationResearch PersonnelRoleSignal PathwaySignal TransductionSignaling MoleculeSurfaceTissuesTranscriptional ActivationUp-RegulationWound Healingin vivoinsightintegrin-linked kinaselung injurynovelprogramsrepairedresponserestorationwound
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): IPF is a deadly disease characterized by the progressive accumulation of fibroblasts within the alveolar wall and airspace with subsequent deposition of collagen in the airspace. During normal lung repair fibroblasts are eliminated by apoptosis permitting restoration of normal anatomic patterns. In contrast, IPF is characterized by the abnormal persistence of fibroblasts in fibrotic foci where they deposit collagen distorting normal lung architecture resulting in organ dysfunction. Identifying key signaling molecules that regulate lung fibroblast viability in a collagen-rich environment will provide insight into the abnormal persistence of fibroblasts in IPF. We have discovered that a B1 integrin PI-3-kinase/Akt viability pathway regulates lung fibroblast survival in collagen matrices. When fibroblasts attach to collagen via B1 integrin Akt is phosphorylated providing a survival signal. However, in response to collagen matrix contraction, Akt becomes dephosphorylated and fibroblasts undergo apoptosis. Enforced activation of the B1 integrin viability pathway rescues fibroblasts from apoptosis. In this revised proposal we will evaluate the identity of the integrin a subunit(s) associated with B1 integrin to determine which integrin is responsible for regulating Akt activity and fibroblast viability in collagen matrices. Furthermore, novel preliminary data we have developed suggest that the molecular mechanism by which collagen matrix contraction promotes apoptosis is by increases in PTEN phosphatase activity resulting in Akt dephosphorylation. Our studies suggest that the mechanism for the increase in PTEN activity involves SHP1-mediated cytoskeletal disassembly. Importantly, we present novel findings indicating that IPF fibroblasts have a distinct phenotype that is characterized by dysfunction of this integrin viability signaling pathway. These observations lead us to hypothesize that: 1) B1 integrin regulation of lung fibroblast viability through the PI-3-kinase/Akt signaling pathway in collagen matrices involves FAK and ILK which activate Akt and PTEN phosphatase which inhibits Akt activity. 2) In response to collagen contraction, SHPl-mediated cytoskeletal disassembly up-regulates PTEN activity inhibiting the B1 integrin viability pathway. 3) Disease specific alterations in the B1 integrin viability pathway and PTEN activity in IPF fibroblasts underlie their altered survival in collagen matrices. To address our hypotheses we will: Aim 1. Identify the integrin a subunit(s) associated with B1 integrin in regulating the Akt viability signal. Aim 2 Investigate the molecular mechanism by which collagen contraction promotes activation of PTEN, Akt dephosphorylation, and fibroblast apoptosis. Examine the role of PTEN in regulating the B1 integrin/PI-3-kinase/Akt survival signal and fibroblast viability. Aim 3. Explore disease-specific alterations in integrin viability signaling and PTEN activity in IPF fibroblasts in a collagen-rich (fibrotic) microenvironment.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
S100A4 Regulation of IPF Mesenchymal Progenitor Cell Fibrogenicity
-
批准号:10371887
-
项目类别:
-
资助金额:$52.3万
-
财政年份:2019
-
负责人:CRAIG A HENKE
-
依托单位:
S100A4 Regulation of IPF Mesenchymal Progenitor Cell Fibrogenicity
-
批准号:9900051
-
项目类别:
-
资助金额:$60.13万
-
财政年份:2019
-
负责人:CRAIG A HENKE
-
依托单位:
Integrin-Matrix Regulation of IPF Fibroblast Phenotype
-
批准号:9099865
-
项目类别:
-
资助金额:$45.85万
-
财政年份:2015
-
负责人:CRAIG A HENKE
-
依托单位:
Administrative Core
-
批准号:8242758
-
项目类别:
-
资助金额:$12.68万
-
财政年份:2011
-
负责人:CRAIG A HENKE
-
依托单位:
Integrin-ECM regulation of fibroblast proliferation
-
批准号:8242755
-
项目类别:
-
资助金额:$41.37万
-
财政年份:2011
-
负责人:CRAIG A HENKE
-
依托单位:
IPF Fibroblast Phenotype
-
批准号:8034790
-
项目类别:
-
资助金额:$167.31万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
IPF Fibroblast Phenotype
-
批准号:7630815
-
项目类别:
-
资助金额:$171.06万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Integrin-collagen signaling and control of fibroblast proliferation
-
批准号:8269781
-
项目类别:
-
资助金额:$16.21万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Integrin-ECM regulation of fibroblast proliferation
-
批准号:7680427
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
IPF Fibroblast Phenotype
-
批准号:8450884
-
项目类别:
-
资助金额:$159.28万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Integrin-collagen signaling and control of fibroblast proliferation
-
批准号:8473261
-
项目类别:
-
资助金额:$15.43万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Integrin-collagen signaling and control of fibroblast proliferation
-
批准号:7647573
-
项目类别:
-
资助金额:$16.37万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Role of Fox03a in Regulating the IPF Fibroblast Phenotype
-
批准号:7932138
-
项目类别:
-
资助金额:$22.65万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
IPF Fibroblast Phenotype
-
批准号:8242760
-
项目类别:
-
资助金额:$167.31万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Integrin-collagen signaling and control of fibroblast proliferation
-
批准号:8076882
-
项目类别:
-
资助金额:$16.37万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Role of Fox03a in Regulating the IPF Fibroblast Phenotype
-
批准号:7691482
-
项目类别:
-
资助金额:$18.88万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Administrative Core
-
批准号:7680430
-
项目类别:
-
资助金额:$34.21万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
IPF Fibroblast Phenotype
-
批准号:7808049
-
项目类别:
-
资助金额:$167.35万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Integrin-collagen signaling and control of fibroblast proliferation
-
批准号:7926963
-
项目类别:
-
资助金额:$16.37万
-
财政年份:2009
-
负责人:CRAIG A HENKE
-
依托单位:
Extracellular Matrix Regulation of Fibroblast Viability
-
批准号:7091578
-
项目类别:
-
资助金额:$32.18万
-
财政年份:2005
-
负责人:CRAIG A HENKE
-
依托单位:
海外基金